SCHEMBL2190359

SCHEMBL2190359

CC(C)(C)c1ccc(Nc2ccncc2[N+](=O)[O-])cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.68
HTT P42858 3/20 0.68
RAB9A P51151 3/20 0.68
GAA P10253 3/20 0.67
MAPT P10636 3/20 0.52
MAPK1 P28482 5/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TRPV1 Q8NER1 1/20 0.43
TDP1 Q9NUW8 3/20 0.42
NPC1 O15118 2/20 0.42
LMNA P02545 1/20 0.42
ATM Q13315 1/20 0.42
CASP7 P55210 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CSNK1D P48730 1/20 0.42
CSNK1G2 P78368 1/20 0.42
PKM P14618 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK3 Q15120 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16657410 0.84 ALDH1A1 (0.74) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL16657372 0.84 ALDH1A1 (0.82) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL27728435 0.82 ALDH1A1 (0.76) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL16657389 0.81 ALDH1A1 (0.74) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL9335042 0.81 ALDH1A1 (0.74) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL16036541 0.81 ALDH1A1 (1.00) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL3952093 0.81 ALDH1A1 (1.00) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL16657408 0.81 ALDH1A1 (0.68) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL4718392 0.81 HTT (1.00) ALDH1A1HTTRAB9AGAAMAPT
SCHEMBL28172411 0.80 MAPK1 (0.68) ALDH1A1HTTRAB9AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519522-B1 SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS ARQULE INC (US) 2014-09-24 EP disclosed
US-8501770-B2 Substituted imidazopyridinyl-aminopyridine compounds ARQULE, INC. (US) 2013-08-06 US disclosed
EP-2519522-A2 SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS ArQule, Inc. (US) 2012-11-07 EP disclosed
US-20110172203-A1 Substituted Imidazopyridinyl-Aminopyridine Compounds ARQULE, INC. (US) 2011-07-14 US disclosed
WO-2011082270-A2 SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS ARQULE. INC. (US) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172203-A1 Substituted Imidazopyridinyl-Aminopyridine Compounds MKI67, CDK4, ABL1 ALDH1A1 651/4885HTT 939/4885RAB9A 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.